Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients-Reference-Cited by-同舟云学术

Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients

Published:2012-11-26 Issue:11 Volume:132 Page:2537-2547
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zuckerman Neta S.,Yu HongXiang,Simons Diana L.,Bhattacharya Nupur,Carcamo-Cavazos Valeria,Yan Ning,Dirbas Frederick M.,Johnson Denise L.,Schwartz Erich J.,Lee Peter P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression;DeNardo;Breast Cancer Res,2007

2. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer;Mahmoud;J Clin Oncol,2011

3. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer;Mahmoud;Breast Cancer Res Treat,2011

4. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002

5. Breast cancer classification and prognosis based on gene expression profiles from a population-based study;Sotiriou;Proc Natl Acad Sci USA,2003

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Different Immune Profiles Are Identified in Sentinel Lymph Nodes of Early-Stage Breast Cancer;Cancers;2024-08-19

2. Alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients;World Journal of Surgical Oncology;2024-06-27

3. Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ;European Journal of Cancer;2024-05

4. Neoantigen‐Based Nanovaccine In Combination with Immune Checkpoint Inhibitors Abolish Postsurgical Tumor Recurrence and Metastasis;Small;2023-08-30

5. Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy;Molecular Oncology;2023-04-24